AUS
NZ
UK
CA
USA
IND
Healt
CSL Ltd and ResMed CDI Share Prices to Monitor
August 07, 2024 12:24 PM AEST| By Team Kalkine MediaIn 2024, CSL Ltd and ResMed CDI have both shown notable performance, with CSL’s share price rising 4.9% since the start of the year and ResMed's trading near its 52-week high. Additionally, another,ASX healthcare stock,worth noting is Cochlear Ltd, w...
ASX Health Stocks: Amplia Achieves Milestone in Pancreatic Cancer Trial
August 06, 2024 05:17 PM AEST| By Team Kalkine MediaAmplia Therapeutics Ltd,(ASX: ATX),has announced a significant milestone in its Phase 2a ACCENT trial for advanced pancreatic cancer. The trial, which examines the efficacy of narmafotinib combined with standard chemotherapy, has reported a confirmed...
Ramsay Share Price Declines Following FY24 Earnings Update
August 05, 2024 06:32 PM AEST| By Team Kalkine MediaRamsay Health Care Ltd,(ASX: RHC),, a major private hospital operator in Australia and Europe, has recently provided an update on its financial performance for the 2024 fiscal year (FY24). Following the announcement, the company’s share price experie...
Ramsay Health Care (ASX:RHC) Shares Tumble Amid Lower Earnings Forecast
August 05, 2024 12:11 PM AEST| By Team Kalkine MediaShares of Ramsay Health Care (ASX:RHC) have plunged as much as 2.1% to AU$44.38 on Monday. The decline comes in response to the company's recent earnings forecast, which has projected a slight decrease in earnings for the fiscal year 2024 (FY24). Thi...
Impressive performance from undervalued ASX healthcare company
August 05, 2024 10:42 AM AEST| By Team Kalkine MediaHighlights:,Solid Q4 Performance,: ResMed (ASX: RMD) reported strong fourth-quarter fiscal 2024 results with a 2% increase in underlying EBIT to USD 400 million and a 62 basis point improvement in gross margin to 59%. Despite these gains, shares are...
ResMed’s Sales Surge Despite Weight-Loss Market Worries
August 02, 2024 02:44 PM AEST| By Team Kalkine MediaResMed Inc.,(ASX: RMD),, a California-based company with origins in Sydney, remains optimistic about the future growth of its sleep apnoea devices. CEO Mick Farrell addressed concerns that recent advances in weight-loss drugs might undermine demand f...
Three ASX Companies Competing to Become the Next Biotech Leaders
July 30, 2024 01:03 PM AEST| By Team Kalkine MediaHighlights:,Growth Potential:,Clarity Pharmaceuticals (ASX: CU6), LTR Pharma (ASX: LTR), and,Opthea,(ASX: OPT) show significant promise in prostate cancer treatment, fast-acting sexual health drugs, and eye disease therapies, respectively, with poten...
ResMed (ASX:RMD) Shares Drop Amid Market Turbulence on Monday
July 29, 2024 06:28 PM AEST| By Team Kalkine MediaDespite a generally buoyant market on Monday, ResMed Inc. (ASX:RMD) found itself under pressure, with its shares declining by 2.14% and closing at AU$30.60. This drop in the stock price followed a significant decline in the company’s NYSE-listed shar...
Cochlear (ASX:COH) Announces Key Changes to Executive Team
July 26, 2024 03:50 PM AEST| By Team Kalkine MediaCochlear Limited (ASX:COH), a global leader in implantable hearing solutions, has announced significant changes to its executive team as part of its strategic leadership transition. These changes reflect the company’s commitment to maintaining its gr...
Polynovo (ASX:PNV) Reports Stellar FY24 Sales of AU$92 Million, Shares Rise 57.1% Year-to-Date
July 24, 2024 04:33 PM AEST| By Team Kalkine MediaShares of Polynovo (ASX:PNV) surged by as much as 6.2% to AU$2.760, marking their highest level since July 2, 2021, as the stock continued its upward momentum from the previous session. Analysts at Macquarie have projected significant sales growth of...
Two ASX Healthcare Stocks Facing Declines Amid Market Challenges
July 24, 2024 02:08 PM AEST| By Team Kalkine MediaOn a challenging Wednesday for the S&P/ASX 200 Index, which sees marginal losses hovering around 7,967.4 points, several stocks stand out for their notable declines. Here’s a closer look at why these healthcare companies are struggling today:,Mesobla...
CSL Ltd and Washington H. Soul Pattinson & Company Ltd Share Prices Worth Watching
July 24, 2024 12:00 AM AEST| By Team Kalkine MediaCSL Ltd,(ASX: CSL),, a leading global biotechnology company, has seen its share price increase by 8.3% since the start of 2024. CSL is known for its innovative medicines that address serious medical conditions and contribute to public health. The com...
Ansell (ASX: ANN) Rises on Strategic Acquisition of Kimberly-Clark's PPE Business
July 23, 2024 04:57 PM AEST| By Team Kalkine MediaAnsell Ltd (,ASX: ANN,), a prominent supplier of medical equipment, saw its shares surge by 3.5% to AU$ 27.570, marking its highest level since July 17, 2023. The rally follows upbeat commentary from analysts at J.P. Morgan regarding Ansell's recent...
_08_02_2023_11_21_17_866226.jpg)
Polynovo’s (ASX: PNV) Share Price Surges 5% on FY24 Results
July 23, 2024 03:22 PM AEST| By Team Kalkine MediaPolynovo Ltd (,ASX: PNV,) has seen its share price climb 5% into the green on Tuesday following the release of its unaudited FY24 trading results. These results indicate robust performance across the board for the medical device company, driving inve...
_05_28_2024_07_35_45_631343.jpg)
Pro Medicus (ASX: PME): Insider Ownership and Institutional Influence
July 22, 2024 10:31 AM AEST| By Team Kalkine MediaPro Medicus Limited (,ASX: PME,),, a prominent player in the healthcare technology sector, showcases a distinct ownership structure that reflects the inherent interests of its key stakeholders in the company’s growth and expansion. Understanding the...
ASX Health Stock: Immutep's Trial Approval, Alcidion's $4M Contract
July 17, 2024 11:40 AM AEST| By Team Kalkine MediaHeadline,Alcidion Signs $4M Contract for Patient Care Platform with HRHA,Immutep and Alcidion Make Strides with Key Approvals and Contracts,Immutep Receives Approval for Phase 1 Trial of Autoimmune Therapy,Immutep (,ASX: IMM,), a biotech company spec...
Mesoblast (ASX: MSB) Faces Share Price Downturn Despite FDA Milestone for Ryoncil
July 09, 2024 01:01 PM AEST| By Team Kalkine MediaDespite a buoyant market, Mesoblast Ltd (,ASX: MSB,), a leading biotechnology firm specialising in allogeneic cellular medicines, is witnessing a downturn in its share price today. As of Tuesday morning trade, the company's shares have dipped by 4.5%...
Ansell (ASX: ANN) Finalises Major Acquisition, Eyes Growth Despite Steady Share Price
July 02, 2024 02:36 PM AEST| By Team Kalkine MediaAnsell Ltd (,ASX: ANN,) has finalised a significant acquisition, acquiring all assets of Kimberly-Clark Corporation's (NYSE: KMB) personal protective equipment (PPE) business. This transaction, initially announced on 8 April 2024, amounts to AU$970 m...
Sonic Healthcare (ASX: SHL) Faces Analyst Caution Amid Challenging Outlook
July 01, 2024 01:58 PM AEST| By Team Kalkine MediaMacquarie's latest forecasts for Sonic Healthcare (,ASX: SHL,) suggest a cautious stance on the company's future earnings, projecting FY25 EBITDA of AU$1.69 billion, which stands 8% below Visible Alpha consensus estimates.,Analyst Rating and Market R...
Healius (ASX: HLS) Shares Tumble on Downgraded FY24 Guidance
June 25, 2024 03:27 PM AEST| By Team Kalkine MediaHealius Limited (,ASX: HLS,) is witnessing a sharp decline in its stock price on 25 June 2024, plummeting as much as 0.33% to AU$1.49 apiece, marking its lowest level since 17 June 2024. The healthcare services provider faces significant challenges t...
Advertise your brand on Kalkine Media